Post by Sanofi

The European Commission has approved our medicine in the European Union for certain people living with secondary progressive multiple sclerosis reinforcing our commitment to advancing scientific innovation that address unmet patient needs.    Read our press release: https://lnkd.in/eWJPPZDt